A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence
Abstract Although a considerable volume of data supporting induction or aggravation of psoriasis because of angiotensin-converting enzyme (ACE) inhibitor use exists, it remains insufficient for definitive conclusions. Therefore, we aimed to evaluate the association between ACE inhibitor use and psor...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06d982a4ce2f487d84650e6eac878820 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:06d982a4ce2f487d84650e6eac878820 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:06d982a4ce2f487d84650e6eac8788202021-12-02T14:35:40ZA systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence10.1038/s41598-021-89490-z2045-2322https://doaj.org/article/06d982a4ce2f487d84650e6eac8788202021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89490-zhttps://doaj.org/toc/2045-2322Abstract Although a considerable volume of data supporting induction or aggravation of psoriasis because of angiotensin-converting enzyme (ACE) inhibitor use exists, it remains insufficient for definitive conclusions. Therefore, we aimed to evaluate the association between ACE inhibitor use and psoriasis incidence through a systematic literature review and meta-analysis. We searched for qualifying studies across PubMed, Web of Science, and Embase. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the association between ACE inhibitor use and psoriasis incidence. Eight studies with a total of 54,509 patients with a psoriasis diagnosis were included in this meta-analysis. The pooled OR for psoriasis incidence among ACE inhibitor users was 1.52 (95% CI, 1.16–2.00) compared to that among non-users. From subgroup analysis by continent, the OR for ACE inhibitor users versus non-users was 2.37 (95% CI 1.28–4.37) in Asia. Per the subgroup analysis by climate, the OR for ACE inhibitor users vs non-users in dry climate was 3.45 (95% CI: 2.05–5.79) vs 1.32 (95% CI 1.01–1.73) in temperate climate. Our results reveal a significant association between ACE inhibitor use and psoriasis incidence.Gonjin SongJi Yea KimHa Young YoonJeong YeeHye Sun GwakNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Gonjin Song Ji Yea Kim Ha Young Yoon Jeong Yee Hye Sun Gwak A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
description |
Abstract Although a considerable volume of data supporting induction or aggravation of psoriasis because of angiotensin-converting enzyme (ACE) inhibitor use exists, it remains insufficient for definitive conclusions. Therefore, we aimed to evaluate the association between ACE inhibitor use and psoriasis incidence through a systematic literature review and meta-analysis. We searched for qualifying studies across PubMed, Web of Science, and Embase. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the association between ACE inhibitor use and psoriasis incidence. Eight studies with a total of 54,509 patients with a psoriasis diagnosis were included in this meta-analysis. The pooled OR for psoriasis incidence among ACE inhibitor users was 1.52 (95% CI, 1.16–2.00) compared to that among non-users. From subgroup analysis by continent, the OR for ACE inhibitor users versus non-users was 2.37 (95% CI 1.28–4.37) in Asia. Per the subgroup analysis by climate, the OR for ACE inhibitor users vs non-users in dry climate was 3.45 (95% CI: 2.05–5.79) vs 1.32 (95% CI 1.01–1.73) in temperate climate. Our results reveal a significant association between ACE inhibitor use and psoriasis incidence. |
format |
article |
author |
Gonjin Song Ji Yea Kim Ha Young Yoon Jeong Yee Hye Sun Gwak |
author_facet |
Gonjin Song Ji Yea Kim Ha Young Yoon Jeong Yee Hye Sun Gwak |
author_sort |
Gonjin Song |
title |
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
title_short |
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
title_full |
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
title_fullStr |
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
title_full_unstemmed |
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
title_sort |
systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/06d982a4ce2f487d84650e6eac878820 |
work_keys_str_mv |
AT gonjinsong asystematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT jiyeakim asystematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT hayoungyoon asystematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT jeongyee asystematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT hyesungwak asystematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT gonjinsong systematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT jiyeakim systematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT hayoungyoon systematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT jeongyee systematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence AT hyesungwak systematicreviewandmetaanalysisofangiotensinconvertingenzymeinhibitoruseandpsoriasisincidence |
_version_ |
1718391052143951872 |